Early and late brain metastases in EGFR wild type and EGFR mutation positive non small cell lung cancer: Implications for survival.

被引：1
|
作者：
Ho, Cheryl
Yamada, Andrew
Weber, Britta
Yuan, Ren
机构：
[1] BC Canc Agcy, Vancouver, BC, Canada
[2] Aarhus Univ Hosp, DK-8000 Aarhus, Denmark
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e19065
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Radiological Features of Brain Metastases from Non-small Cell Lung Cancer Harboring EGFR Mutation
    Takamori, Shinkichi
    Toyokawa, Gouji
    Shimokawa, Mototsugu
    Kinoshita, Fumihiko
    Kozuma, Yuka
    Matsubara, Taichi
    Haratake, Naoki
    Akamine, Takaki
    Mukae, Nobutaka
    Hirai, Fumihiko
    Tagawa, Tetsuzo
    Oda, Yoshinao
    Iwaki, Toru
    Iihara, Koji
    Honda, Hiroshi
    Maehara, Yoshihiko
    ANTICANCER RESEARCH, 2018, 38 (06) : 3731 - 3734
  • [22] DISTINCT CHARACTERISTICS OF BRAIN METASTASES FROM NON-SMALL LUNG CANCER WITH EGFR MUTATION
    Sekine, Akimasa
    Kato, Terufumi
    Ogura, Takashi
    RESPIROLOGY, 2013, 18 : 7 - 7
  • [23] Afatinib in EGFR mutation positive advanced non-small cell lung cancer
    Davies, R. S.
    Brewster, A. E.
    Button, M. R.
    Lester, J. F.
    LUNG CANCER, 2016, 91 : S22 - S22
  • [24] Management of EGFR Mutation-Positive Non-Small Cell Lung Cancer
    Lilenbaum, Rogerio A.
    Horn, Leora A.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2016, 14 (5.5): : 672 - 674
  • [25] A study of EGFR wild-type non-small cell lung cancer ALK genetic mutation
    Wang, Shoufeng
    Mao, Naiquan
    Zuo, Chuantian
    Pan, Hong
    Xie, Tong
    Huang, Yaoyuan
    Pan, Qi
    Wu, Junwei
    TRANSLATIONAL CANCER RESEARCH, 2017, 6 (05) : 976 - 980
  • [26] EGFR mutation status and survival after diagnosis of brain metastasis in non-small cell lung cancer
    Eichler, A. F.
    Kahle, K. T.
    Wang, D. L.
    Joshi, V. A.
    Engelman, J. A.
    Sequist, L. V.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [27] Real-world disease burden and outcomes of brain metastases in EGFR mutation-positive non-small-cell lung cancer
    Nadler, Eric
    Espirito, Janet L.
    Pavilack, Melissa
    Baidoo, Bismark
    Fernandes, Ancilla
    FUTURE ONCOLOGY, 2020, 16 (22) : 1575 - 1584
  • [28] EGFR Tyrosine Kinase Inhibitor and Chemotherapy in EGFR Mutation-Positive Non-Small Cell Lung Cancer
    Nishino, Kazumi
    Kimura, Madoka
    Inoue, Takako
    Uchida, Junji
    Kumagai, Toru
    Imamura, Fumio
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S526 - S526
  • [29] The role of EGFR inhibitors as adjuvant therapy for EGFR mutation positive non-small cell lung cancer.
    Xie, Peng
    Tang, Wenjie
    Li, Xiaolin
    Sun, Xindong
    Yu, Jinming
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [30] EGFR plasma mutation in prediction models for resistance with EGFR TKI and survival of non-small cell lung cancer
    Thang Thanh Phan
    Bich-Thu Tran
    Son Truong Nguyen
    Toan Trong Ho
    Hang Thuy Nguyen
    Vu Thuong Le
    Anh Tuan Le
    CLINICAL AND TRANSLATIONAL MEDICINE, 2019, 8
12345